Tenaya Therapeutics, Inc. (TNYA)
0.7941
+0.01
(+1.42%)
USD |
NASDAQ |
May 19, 16:00
0.7941
0.00 (0.00%)
After-Hours: 17:19
Tenaya Therapeutics Research and Development Expense (Quarterly) : 14.84M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 2.843M |
| Alnylam Pharmaceuticals, Inc. | 364.87M |
| Krystal Biotech, Inc. | 13.81M |
| Vericel Corp. | 8.104M |
| Anavex Life Sciences Corp. | 4.656M |